Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2010 Nov;24(11):651-5.
doi: 10.1155/2010/407095.

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Richard N Fedorak  1 , Karen Wong, Ron Bridges
Affiliations
Review

Canadian Digestive Health Foundation Public Impact Series. Inflammatory bowel disease in Canada: Incidence, prevalence, and direct and indirect economic impact

Richard N Fedorak et al. Can J Gastroenterol. 2010 Nov.

Abstract
in English, French

The Canadian Digestive Health Foundation initiated a scientific program to assess the incidence, prevalence, mortality and economic impact of digestive disorders across Canada in 2009. The current article presents the updated findings from the study concerning inflammatory bowel diseases - specifically, Crohn's disease and ulcerative colitis.

La Fondation canadienne pour la promotion de la santé digestive a lancé un programme scientifique pour évaluer l’incidence, la prévalence, la mortalité et les conséquences économiques des maladies digestives au Canada en 2009. Le présent article expose les résultats à jour de l’étude au sujet des maladies inflammatoires de l’intestin, notamment la maladie de Crohn et la colite ulcéreuse.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Incidence rates of Crohn’s disease (CD) and ulcerative colitis (UC) in Canada. Data from reference
Figure 2
Figure 2
Provincial distribution of Crohn’s disease (CD) and ulcerative colitis (UC) patients in 2007/2008. AB Alberta; BC British Columbia; MB Manitoba; NB New Brunswick; NF Newfoundland and Labrador; NS Nova Scotia; NU Nunavut; NWT Northwest Territories; ON Ontario; PE Prince Edward Island; QC Quebec; SK Saskatchewan; YU Yukon. Data from the Canadian Common Household Survey, cycle 4.1 (7)
Figure 3
Figure 3
Growth of Crohn’s disease (CD) and ulcerative colitis (UC) populations in Canada. Data compiled and adapted from three population based surveys: Bernstein et al (1) (1998 to 2000), 2007/2008 Canadian Common Household Survey cycle 4.1 (7) and the 2005 Canadian Common Household Survey cycle 3.1 (8)
Figure 4
Figure 4
Canadians with chronic diseases categorized according to age group for 2008. Arrows highlight the age groups uniquely affected by Crohn’s disease and ulcerative colitis. yrs Years. Data adapted from the Canadian Common Household Survey cycle 4.1 (7)
Figure 5
Figure 5
Number of mortalities each year primarily attributed to Crohn’s disease (disease code K50) or ulcerative colitis (disease code K51). Data adapted from reference
Figure 6
Figure 6
Global sales of gastrointestinal anti-inflammatories including mesalamine, hydrocortisone, balsalazide, budesonide and others (representing 19% to 31% of total annual sales). Sales for 2005 and 2006 represent 246 products, while sales figures for 2007 to 2009 represent the combined total for 315 products. Data from reference
Figure 7
Figure 7
Number of physician consultations (Consults) for Crohn’s disease (CD) and ulcerative colitis (UC) compared with the number of physician consults among the general population in 2007/2008. Data from the Canadian Common Household Survey, cycle 4.1 for 2007/2008 (7)
Figure 8
Figure 8
Estimated hospitalization costs for treatment of inflammatory bowel disease in 2008. Values obtained from the Patient Cost Estimator for 2008 (18). Est Estimated; No Number; yr Year(s)
Figure 9
Figure 9
Percentage of Canadians permanently unable to work categorized according to chronic disease type. Data obtained from the Canadian Common Household Survey, cycle 4.1 (7)
See this image and copyright information in PMC

References

    1. Bernstein CN, Wajda A, Svenson LW, et al. The epidemiology of inflammatory bowel disease in Canada:A population-based study. Am J Gastroenterol. 2006;101:1559–68. - PubMed
    1. Statistics Canada. Quarterly Demographic Estimates. [Accessed on July 28, 2010]. < http://www.statcan.gc.ca/daily-quotidien/100628/dq100628a-eng.htm>.
    1. Lowe AM, Roy PO, Poulin MB, et al. Epidemiology of Crohn’s disease in Quebec, Canada. Inflamm Bowel Dis. 2009;15:429–35. - PubMed
    1. Economou M, Pappas G. New global map of Crohn’s disease: Genetic, environmental, and socioeconomic correlations. Inflamm Bowel Dis. 2008;14:709–20. - PubMed
    1. Statistics Canada. Population by sex and age group, CANSIM, Table 051-0001. [Accessed on May 14, 2010]. < http://www40.statcan.gc.ca/l01/cst01/demo10a-eng.htm>.

LinkOut - more resources